10% Free customization
Peritoneal dialysis is a critical treatment for patients with kidney failure, effectively removing waste products from the blood when the kidneys are no longer able to filter efficiently. This process involves introducing a cleansing solution into the abdominal cavity, using the peritoneum as a natural filter. After a designated dwell time, the fluid containing waste is drained and discarded. Unlike hemodialysis, peritoneal dialysis can be managed independently by the patient or caregiver and is highly flexible, allowing treatment at home, work, or while traveling.This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The growing prevalence of chronic kidney disease (CKD) is a primary driver of the peritoneal dialysis market. According to the Institute for Health Metrics and Evaluation, the global burden of chronic kidney disease reached 7.89 billion cases in 2021, up from 7.82 billion in 2020. This rising population of CKD patients has fueled increased demand for peritoneal dialysis as an effective treatment option. The market is further supported by the global rise in diabetes and hypertension, both of which are major risk factors for kidney disease. An August 2023 report from the National Center for Biotechnology Information on diabetes and hypertension prevalence highlighted that, in 2.02 trillion people were living with diabetes, while the World Health Organization reported over one billion people globally with hypertension.
Additionally, technological advancements are enhancing market growth. Innovations in dialysis equipment, such as portable systems and improved dialysis solutions are making peritoneal dialysis more accessible and effective. Additionally, the shift toward home-based healthcare solutions presents a favorable market opportunity, as peritoneal dialysis can be administered at home, allowing patients to maintain their daily routines and travel if necessary.
Despite these growth drivers, the peritoneal dialysis market faces notable challenges. Peritonitis, a potentially life-threatening infection of the peritoneum, remains a significant complication and a barrier to broader adoption. Furthermore, the process requires rigorous patient or caregiver adherence to aseptic techniques, as any lapses can lead to serious infections, which may discourage uptake.
In the Asia-Pacific region, the peritoneal dialysis market is poised for robust growth, driven by a high incidence of chronic kidney disease. As per a report published in January 2022 by the National Center for Biotechnology Information, an estimated 434.3 million adults in Asia had chronic kidney disease, with up to 65.6 million in advanced stages. This escalating patient base is expected to drive market demand over the forecast period.
Market Segmentation:
Segmentation 1: by Product
- Peritoneal Dialysis Solution Bags
- Peritoneal Dialysis Cyclers
- Dialysis Accessories and Other products (Cathers, Drain Bag, etc.)
Segmentation 2: by Indication
- Acute Kidney Injuries
- END-Stage Renal Diseases
- Other Renal Diseases
Segmentation 3: by Type
- Automated Peritoneal Dialysis (APD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
Segmentation 4: by End User
- Hospitals and Dialysis Centers
- Homecare
- Others
Segmentation 5: by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
How can this report add value to an organization?
Product/Innovation Strategy: This report provides a comprehensive product/innovation strategy for the global peritoneal dialysis market, identifying opportunities for market entry, technology adoption, and sustainable growth. It offers actionable insights, helping organizations gain a competitive edge, and capitalize on the increasing demand.Growth/Marketing Strategy: This report offers a comprehensive growth and marketing strategy designed specifically for the peritoneal dialysis market. It presents a targeted approach to identifying specialized market segments, establishing a competitive advantage, and implementing creative marketing initiatives aimed at optimizing market share and financial performance. By harnessing these strategic recommendations, organizations can elevate their market presence, seize emerging prospects, and efficiently propel revenue expansion.
Competitive Strategy: This report crafts a strong competitive strategy tailored to the peritoneal dialysis market. It evaluates market rivals, suggests methods to stand out, and offers guidance for maintaining a competitive edge. By adhering to these strategic directives, companies can position themselves effectively in the face of market competition, ensuring sustained prosperity and profitability.
This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.
Table of Contents
Executive SummaryScope of the Study8. Research Methodology
1. Global Peritoneal Dialysis Market: Industry Outlook
2. Global Peritoneal Dialysis Market, by Type, $Million, 2023-2034
3. Global Peritoneal Dialysis Market, by Product, $Million, 2023-2034
4. Global Peritoneal Dialysis Market, by Indication $Million, 2023-2034
5. Global Peritoneal Dialysis Market, by End User, $Million, 2023-2034
6. Global Peritoneal Dialysis Market, by Region, $Million, 2023-2034
7. Competitive Landscape and Company Profiling
Companies Mentioned
- Baxter International Inc.
- Fresenius Medical Care AG
- B. Braun SE
- Huaren Pharmaceutical Co. Ltd.
- Asahi Kasei Corporation
- Terumo Corporation
- Medtronic Plc
- Becton, Dickinson and Company
- Utah Medical Products, Inc.
- Medionics
- Newsol Technologies Inc.